Optics News

by Nicholas Theodore, MD

ATLANTA – Eyenovia is evaluating atropine for progressive myopia and pilocarpine for presbyopia in several studies using the company’s Optejet microdose dispenser.

Data from a literature review showed that low-concentration atropine was effective in myopia control and may help prevent myopia progression in high-risk children.

Researchers based in the Netherlands, Australia, the U.K. and the U.S. reported that there was no genetic correlation between myopia and primary open-angle glaucoma.

ATLANTA — Physicians have noted that steadily increasing digital device use among children is becoming a significant health issue, and optometrists have found patterns linking extensive screen time and altered visual acuity, according to a presenter at SECO.

by Anthony P. Kontos, PhD

A 20-year-old woman presented for a neuro-optometric exam with complaints of headaches, asthenopia, occasional diplopia, extreme light sensitivity, dizziness and loss of balance. She reported her symptoms started about 2 years ago with day-to-day fluctuations in her symptoms.

CooperVision introduced the Brilliant Futures Myopia Management Program to create a new standard of care for children with myopia, as the company prepares to launch its myopia control contact lens.

by Leonard V. Messner OD, FAAO

The International Myopia Institute has formed task forces to follow up its research released in a series of white papers in 2019 and reinforced advocacy efforts to keep myopia a major public eye health issue.